drugset / Trial / NCT01066689
Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Assessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"
Timeline
- Start
- 2008-10
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | Intravenous |